- MMG’s board approved a further revised annual cap under the Rosebery Concentrate Sales Agreement, raising the cap to USD 150 million.
- Directors Cao Liang, Zhang Shuqiang, Zhao Jing Ivo, Qian Song, and Yue Wenjun abstained from voting on the resolution due to their positions at CMC and/or CMN.
- The company said the revision was driven by higher-than-expected copper, gold, and silver prices affecting the final pricing adjustment for product delivered in 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MMG Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12072850), on March 27, 2026, and is solely responsible for the information contained therein.
Comments